Business
SYNBIOTIC strengthens its presence at international events and monitors advances in cannabis research
SYNBIOTIC strengthens its presence at international events and monitors advances in cannabis research
About this update from Synbiotic Se
SYNBIOTIC SE/ Key word(s): Strategic Company Decision SYNBIOTIC strengthens its presence at international events and monitors advances in cannabis research 18.11.2025 / 10:41 CET/CESTThe issuer is solely responsible for the content of this announcement.SYNBIOTIC strengthens its presence at international events and monitors advances in cannabis research The European medical cannabis and industrial hemp group SYNBIOTIC SE (ISIN | WKN A3E5A5) is entering the final stretch of the year with strategic initiatives: The Group has already participated in the international Talman House Roadshow in London and will be represented at the Equity Capital Forum in Frankfurt. At the same time, SYNBIOTIC points to current scientific findings on the so-called entourage effect and emphasizes the importance of natural full-spectrum approaches to CBD products.SYNBIOTIC at the Talman House Event 2025 in London As part of its ongoing capital market activities, SYNBIOTIC presented itself on 10 November 2025 as a sponsor and participant at the Talman House Event in London. The renowned industry meeting brings together leading players from the cannabis, healthcare and investment sectors to discuss the future of sustainable and innovative markets. SYNBIOTIC used the event to deepen its exchange with international investors and partner companies and to provide insights into the current development of the Group. “Talman House is an excellent platform to bridge innovative European cannabis companies with international capital providers. For SYNBIOTIC, it is a valuable opportunity to strengthen our network and further expand the Group’s visibility,” said Daniel Kruse, Managing Director of SYNBIOTIC. The event also served to continue close collaboration with the intercontinental network – including Hyde Advisory, Bob Hoban, Global Cannabis Network Collective and Golden Eagle Partners.German Equity Capital Forum 2025 SYNBIOTIC will also be represented at the Equity Capital Forum 2025 from 24 to 26 November in Frankfurt. The aim is to demonstrate to institutional investors the positive development of a sector positioned in the areas of “Health Care,” “Food & Beverage,” and “Consumer Goods,” and to present the Group’s strategic developments.Research confirms potential of the entourage effect – SYNBIOTIC focuses on full-spectrum approaches Recent research findings once again highlight the si...